USPTO trademark

JEXFLUVA

Awaiting publicationUSPTOWord markClass 5

"JEXFLUVA" is a word mark owned by GlaxoSmithKline Biologicals SA, filed at the USPTO on September 14, 2026. It is waiting to be published and covers class 5 (Pharmaceuticals).

View GlaxoSmithKline Biologicals SA portfolioGet this data via the API
Official USPTO record
JEXFLUVA trademark as filed
As filed with the USPTO
Status
Awaiting publication
Since October 21, 2026
Filed
September 14, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50106129
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns JEXFLUVA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GlaxoSmithKline Biologicals SA

Rixensart, Belgium

3,098 trademarks in the portfolioView company

Representative

Christopher M. Hanes

GSK

Goods and services

What the mark covers

The products and services JEXFLUVA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Approved for pub - principal register
  2. Assigned to examiner
  3. Application filing receipt mailed
  4. New application office supplied data entered
  5. New application entered
FAQ

About JEXFLUVA

Who owns the trademark "JEXFLUVA"?

The USPTO trademark "JEXFLUVA" (application 50106129) is owned by GlaxoSmithKline Biologicals SA.

What is the status of "JEXFLUVA"?

Its status at the USPTO is: awaiting publication.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull JEXFLUVA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0a531-5cf9-73d5-a916-f9cede910951
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0a531-5cf9-73d5-a916-f9cede910951",
  "object": "trademark",
  "mark_text": "JEXFLUVA",
  "status": {
    "primary": "pending",
    "stage": "pending_publication"
  },
  "office_code": "US",
  "application_number": "50106129",
  "filing_date": "2026-09-14",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "GlaxoSmithKline Biologicals SA",
      "entity_id": "ent_019eb6fa-f71d-76cb-987c-9c96b2781170"
    }
  ]
}